They also found that COL11A1 expression increased during ovarian cancer progression, and downregulation of COL11A1 in ovarian cancer cells could significantly inhibit tumor growth in vivo (Cheon et al., 2014). The gene discussed is COL11A1; the disease is ovarian carcinoma.